Aortic & peripheral vascular disease

Safety and effectiveness of drug-coated devices in chronic limb-threatening ischaemia: a nationwide analysis

EuroInterventionPublished

  • national real-world chronic limb-threatening ischaemia (CLTI) cohort
  • nationwide
  • Medicare beneficiaries
  • multivariable Cox and gamma regression models
+3 more
  • nationwide
  • Medicare beneficiaries
  • multivariable Cox and gamma regression models

Authors' conclusion

In this national CLTI cohort, drug-coated devices were associated with reduced amputation and mortality. Data from this study suggest that DCBs may offer consistent benefit without increased costs.

Study context

Population
Medicare beneficiaries aged ≥66 years who underwent femoropopliteal revascularisation for CLTI between 2016 and 2023
Participants
108,304 CLTI patients
Exposure
PBA±BMS vs drug-coated balloons (DCBs)±BMS vs drug-eluting stents (DES)
  • PBA±BMSn = 52.5%reference
  • DCB±BMSn = 30.7%
  • DESn = 16.8%

Main finding

As reported in the abstract

Composite of:
  • All-cause mortality
  • Major amputation
· 2 years

Observational data: associations, not effects.

Further findings

OutcomePBA±BMSDCB±BMSDESHR (95% CI)
Composite of all-cause mortality or major amputation · 5 years — DCB±BMS vs PBA±BMS · lower risk75.69%71.19%71.71%0.92 (0.90–0.93)
Composite of all-cause mortality or major amputation · 5 years — DES vs PBA±BMS · lower risk0.93 (0.92–0.95)
Major amputation, mortality, MALE and reintervention (DCBs) · major amputation0.87 (0.84–0.91)
Major amputation, mortality, MALE and reintervention (DCBs) · mortality0.93 (0.91–0.94)
Major amputation, mortality, MALE and reintervention (DCBs) · MALE0.96 (0.94–0.98)
Major amputation, mortality, MALE and reintervention (DCBs) · reintervention0.97 (0.96–0.99)
OutcomePBA±BMSDCB±BMSDESEstimate
Proportion of BMS use10.1%3.1%Not reported in the abstractDES: not reported in the abstract

Original publication

Safety and effectiveness of drug-coated devices in chronic limb-threatening ischaemia: a nationwide analysis. EuroIntervention. Published 2 March 2026. doi:10.4244/eij-d-25-00769

Summarised from the published abstract; every number is checked against it